US 12,171,774 B2
Topical analgesic
Tony LaRosa, Woodland Hills, CA (US); Robert Davidson, Thousand Oaks, CA (US); and David Reid, Newbury Park, CA (US)
Filed by Concept Matrix Solutions, Newbury Park, CA (US)
Filed on Jul. 20, 2022, as Appl. No. 17/813,676.
Application 17/813,676 is a continuation of application No. 17/467,629, filed on Sep. 7, 2021, granted, now 11,439,654.
Application 17/467,629 is a continuation of application No. 16/928,664, filed on Jul. 14, 2020, granted, now 11,116,780, issued on Sep. 14, 2021.
Claims priority of provisional application 62/987,080, filed on Mar. 9, 2020.
Claims priority of provisional application 62/977,851, filed on Feb. 18, 2020.
Claims priority of provisional application 62/907,749, filed on Sep. 30, 2019.
Claims priority of provisional application 62/875,583, filed on Jul. 18, 2019.
Prior Publication US 2022/0378812 A1, Dec. 1, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/7034 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/045 (2006.01); A61K 31/05 (2006.01); A61K 31/522 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/24 (2006.01); A61K 47/32 (2006.01); A61K 47/44 (2017.01)
CPC A61K 31/7034 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/522 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61K 47/32 (2013.01); A61K 47/44 (2013.01)] 20 Claims
 
1. A method for the temporary relief of aches or pains of affected muscles or joints areas, the method comprising topically administering to the affected areas of a subject in need thereof a topical analgesic comprising:
menthol, present in 2.5±0.5 wt. %;
cannabidiol (CBD), present in 0.33±0.07 wt. %;
carbopol, present in 1.4±0.3 wt. %;
lecithin, present in 2±0.4 wt. %;
caffeine anhydrous, present in 1.5±0.3 wt. %;
salicin, present in 1.25±0.25 wt. %;
organic hemp oil, present in 1±0.2 wt. %;
sodium benzoate, present in 0.1±0.02 wt. %;
tocopheryl acetate, present in 0.2±0.04 wt. %;
sodium bicarbonate, present in 1.5±0.3 wt. %; and
water;
wherein,
the topical analgesic is configured and formulated as a cream, lotion, or roll-on liquid.